AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 223 filers reported holding AXSOME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,071,089 | -2.7% | 58,300 | 0.0% | 1.37% | +7.6% |
| Q2 2023 | $4,185,940 | +569.8% | 58,300 | +316.4% | 1.27% | +537.0% |
| Q3 2022 | $625,000 | -95.5% | 14,000 | +2516.8% | 0.20% | +37.0% |
| Q2 2022 | $14,000,000 | +159.2% | 535 | -96.2% | 0.15% | -88.0% |
| Q1 2022 | $5,402,000 | +1071.8% | 14,000 | 0.0% | 1.22% | +997.3% |
| Q3 2021 | $461,000 | -51.2% | 14,000 | 0.0% | 0.11% | -55.4% |
| Q2 2021 | $944,000 | +19.0% | 14,000 | 0.0% | 0.25% | +18.6% |
| Q1 2021 | $793,000 | -30.4% | 14,000 | 0.0% | 0.21% | -32.5% |
| Q4 2020 | $1,140,000 | – | 14,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |